Compare Halliburton Company (HAL) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halliburton Company vs UnitedHealth Group Inc — how do they compare? Halliburton Company trades at $33.8 (market cap $28.03B), while UnitedHealth Group Inc trades at $402.51 (market cap $371.19B). The key difference: UnitedHealth Group Inc is far larger — about 13.2× Halliburton Company's market cap, and UnitedHealth Group Inc pays the higher dividend (2.27%). Which is the better fit depends on your goals.
| HAL | UNH | |
|---|---|---|
Market Cap | $28.03B | $371.19B |
Sector | Energy | Health |
52-Week High | $42.98 | $436.35 |
52-Week Low | $20.97 | $259.02 |
Enterprise Value | $34.18B | $417.88B |
Dividend Yield | 2.02% | 2.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Halliburton (HAL) trades at $31.89, down 1.91% amid technical bearish signals despite strong fundamentals. The company reported Q2 2026 EPS of $0.55, beating estimates, with revenue growth driven by international contracts. Valuation metrics remain attractive with P/E of 16.7 and P/S of 1.2, while analyst consensus shows 73% buy ratings with a $43.60 price target. Recent news highlights contract wins in Kuwait and Australia, though Middle East volatility presents near-term headwinds.
HAL offers value with solid earnings momentum and global expansion, but faces execution risks from geopolitical tensions and oil market volatility. The stock's current discount to analyst targets presents opportunity, though technical weakness suggests cautious entry timing. Long-term growth prospects remain intact through technology leadership and international contract pipeline.
UnitedHealth Group (UNH) trades at $402.19, down 1.2% in the last session, with a bearish technical signal but strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has consistently beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
Outlook remains positive due to aging demographics and Medicare growth, though regulatory risks and margin pressure present challenges. With 82.7% of analysts rating it a Buy and a consensus price target of $476.50, the stock offers upside potential, balanced by litigation and competitive threats in the managed care sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halliburton Company
Halliburton is one of the three largest oilfield service firms in the world, offering superior expertise in a number of business lines, including completion fluids, wireline services, cementing, and countless others. It's the number one pressure pumper in North America, and has been a leading innovator in hydraulic fracturing over the last two decades.
Read more on HAL →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
